Utah Medical Products Financial Overview
Utah Medical Products's market cap is currently $181.36M. The company's EPS TTM is $0.82; its P/E ratio is 16.11; and it has a dividend yield of 2.16%. Utah Medical Products is scheduled to report earnings on October 23, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
